A review of the role of serotonin receptors in psychiatric disorders

Human Psychopharmacology

Volumn 15, Issue 6, 2000, Pages 397-415

  Gijsman, Harm J ^a,b,d   Verkes, Robbert Jan ^a,b   Schouten Verhagen, Jolanda C M ^c   Schoemaker, Rik C ^a   Van Gerven, Joop M A ^a   De Rijk, Roel H ^c   Van Kempen, Godfried M J ^b,c  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Biochemical Laboratory   (Netherlands)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anxiety; Cognitive disorders; Depression; Eating disorders; Migraine; Psychotic disorders; Serotonin receptors; Sexual disorders; Sleep disorders

Indexed keywords

SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1E RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR;

ANXIETY; DEPRESSION; EATING DISORDER; HUMAN; MENTAL DISEASE; MIGRAINE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; RECEPTOR BINDING; REVIEW; SEROTONINERGIC SYSTEM; SEXUAL FUNCTION; SLEEP DISORDER;

EID: 0033817761     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L     Document Type: Review

References (169)

1. 1 receptor subtype coupled to the inhibition of adenyl cyclase
2. Evidence for a unique pharmacological profile of 8-OH-DPAT by evaluation of its effects on male sexual behaviour
3. The inhibitory modulation of agonistic behaviour in the rat brain: A review
4. 3 receptor antagonist on cognition in rodents and primates
5. 3 receptors ligands
6. Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and the hippocampal formation
7. Trazadone treatment response in obosessive compulsive disorder correlated with shifts in glucose metabolism in the caudate nuclei
8. 2 receptor subtypes, a family re-united?
9. 3 antagonists in neuropsychiatric disorders
10. Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?
11. Involvement of 5-HT(1C) receptors in drug induced penile erection in rats
12. 2 receptor binding on blood platelets - A peripheral marker for depression?
13. 2 receptor binding on blood platelets of suicidal men
14. 2 receptor binding on blood platelets as a state dependent marker in major affective disorder
15. Current advances in the treatment of depression
16. Modification of the serotonin system by antidepressant treatment: Implications for the therapeutic response in major depression
17. 4 receptor: A place in the sun
18. 4 receptors potential therapeutic implications in neurology and psychiatry
19. Molecular biology of 5-HT receptors
20. The pharmacology and distribution of human 5-hydroxytryptamine(2B) (5-HT(2B)) receptor gene product: Comparison with 5-HT(2A) and 5-HT(2C) receptors
21. 6 receptor in the rat brain: A study using antisense oligonucleotides
22. The characterisation of 5-HT receptors
23. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
24. Towards a unified theory of serotonin dysregulation in eating and related disorders
25. Behavioural, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment
26. The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioural and physiological responses in young healthy controls
27. The anti-migraine drugs ergotamine and dihydroergotamine are potent 5-HT(1C) receptor agonists in pig choroid plexes
28. Serotonin-specific drugs for anxiety and depressive disorders
29. Rational drug use in the treatment of depression
30. Buspirone attenuates volitional alcohol intake in chronically drinking monkeys
31. Drugs interacting with 5-HT systems show promise for treatment of eating disorders
32. 3 receptors
33. Elevatred alcohol consumption in null mutant mice lacking 5-HT(1B) serotonin receptors
34. Actions and some interactions of 5-HT(1A) ligands in the elevated X-maze and effects of dorsal raphe lesions
35. Effects of ondansetron in age-associated memory impairment
36. A double blind placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepan in patients with generalized anxiety disorder. A prospective multicentre trial
37. Experimental tests of the 5-HT receptor imbalance theory of affective disorders
38. The pharmacological profile of mirtazapine
39. Serotonin and the neurobiology of depression: Effects of tryptophan depletion in drug free depressed patients
40. Behavioural pharmacology of the 5-HT(1A) receptor ligands ipsapirone and 8-OH-DPAT in rats after repeated administration
41. Behavioural pharmacology of 5-HT(1A) agonists: Animal models of anxiety and depression
42. 5-HT(1A) receptor agonists: Recent developments and controversial issues
43. 1-like receptor agonist for the acute treatment of migraine
44. 2 receptors in the regulation of sleep and wakefulness in the rat
45. 4 receptors
46. Nefazadone: Preclinical pharmacology of a new anti-depressant
47. Effect of chronic administration of antidepressant drugs on 5-HT-mediated behaviour in the rat following noradrenergic or serotonergic denervation
48. Pharmacology of enteramine. I. Action of acetone extract of rabbit stomach mucosa on blood pressure and on surviving isolated organs
49. Response of anxiety and agitation symptoms during nefazodone treatment of major depression
50. Clinical and experimental effects of sumatriptan in humans
51. Cloning and functional expression of the rat stomach fundus serotonin receptor
52. 5-HT(1C) receptor agonism as an initiating event in migraine
53. Serotonin
54. Two kinds of tryptamine receptor
55. 5-HT(1A) receptors and anti-depressant drug action
56. 5-HT(1D) receptors: A serotonin receptor population for the 1990s
57. 5-HT(1A) partial agonists: What is their future?
58. Buspirone, a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic
59. G protein-coupled receptors
60. Human S31 serotonin receptor encodes a 5-HT(1E)-like serotonin receptor
61. 1 receptor agonists, CP-122,288, a selective inhibitor of neurogenic inflammation
62. Noradrenergic modulation of central serotonergic neurotransmission: Acute and long-term actions of mirtazapine
63. CCK in animal and human research on anxiety
64. Molecular biology of 5-HT receptors
65. A subfamily of 5-HT(1D) receptor genes
66. Monoamine related markers of depression
67. Elevated anxiety and antidepressant-like responses in serotonin 5-HT(1A) receptor mutant mice
68. Serotonin receptors, agents and actions
69. International union of pharmacology classification of receptors for serotonin
70. A proposed new nomenclature for 5-HT receptors
71. Serotonin, motor activity, depression and related disorders
72. Molecular biology of serotonin receptors
73. Serotonin-dopamine interaction and its relevance to schizophrenia
74. 7 receptor stimulation of GABA-A receptor-activated current in cultured rat suprachiasmatic neurons
75. 2 receptors in rat brain
76. Evidence that mCPP may have behavioural effects mediated by central 5-HT(1C) receptors
77. Potencies of antagonists indicate that 5-HT(1C) receptors mediate mCPP-induced hypophagia
78. Anxiogenic-like effects of m-CPP and TFMPP in animal models are opposed by 5-HT(1C) receptor antagonists
79. In vivo properties of SB200646A, a 5-HT(2B/2C) receptor antagonist
80. The effects of 5-HT(2B) receptor agonist BW723C86, in 3 models of anxiety
81. The 5-HT(2B) receptor agonist BW723C86 increases feeding and reduces grooming in rats
82. 3 receptors
83. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: A double-blind placebo controlled study
84. Pharmacological characteristics of in vivo properties of putative mixed 5-HT(1A) agonist/5-HT(2A/2C) antagonist anxiolytics. 1. Anti-punishment effects in the pigeon
85. Differential regulation of rat 5-HT(2A) and 5-HT(2C) receptor after chronic treatment with clozaprine, chlorpromazine and three putative atypical antipsychotic drugs
86. Molecular cloning, functional expression and mRNA tissue distribution of the human 5-hydroxytryptamine(2B) receptor
87. 25 years since the discovery of presynaptic receptors: Present knowledge and future perspectives
88. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia
89. Serotonin - A neurotransmitter, a neuromodulator, a growth factor - The 'jack of all trades'
90. Serotonin receptors - Where are they going?
91. Detection of a novel serotonin receptor subtype (5-HT(1E) in human brain: Interaction with GTP-binding protein
92. Serotonin(1A) receptor messenger RNA regulation in the hippocampus after acute stress
93. 3 receptor mediated ion current in NCB-20 neuroblastoma cells
94. 3 receptor mediated ion-channel innodose ganglion neurons from the adult rat
95. New players in the 5-HT receptor field: Genes and knockouts
96. 5-Hydroxytryptamine(1B) receptors modulate the effects of cocaine on c-fos expression: Converging evidence using 5-hydroxytryptamine(1B) knockout mice and 5-hydroxytryptamine(1B/1D) antagonist GR127935
97. 3 receptor, a serotonin gated ion-channel
98. Receptors for 5-hydroxytryptamine, current perspectives on classification and nomenclature
99. Mouse 5-hydroxytryptamines(5A) and 5-HT(5B) receptors define a new famiily of serotonin receptors: Cloning functional expression and chromosomal localization
100. Molecular cloning of a serotonin receptor from human brain
101. Acute rise in corticosterone facilitates 5-HT(1A) receptor-mediated behavioural responses
102. Clinical studies on the mechanism of action of clozapine, the dopamine-serotonin hypothesis of schizophrenia
103. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs
104. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
105. Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rat
106. 2 receptor antagonists and migraine therapy
107. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT(2C) receptor gene
108. Serotonin receptors and animal models of aggressive behaviour
109. Anxiety of mice lacking the serotonin(1A) receptor
110. 5HT receptors in human and animal cerebrovasculature
111. Serotonin(1B) receptor stimulation enhances cocaine reinforcement
112. Localization of serotonin-4 receptors in the striatonigral pathway in the rat brain
113. The molecular evolution of G protein coupled receptors: Focus on 5-hydroxytryptamine receptors
114. Efficacy of drug treatment in obsessive compulsive disorder: A meta-analytical review
115. 5 receptor reveals a remarkable heterogencity within the 5-HT(1D) receptor family
116. 2 receptors and behavioural super-sensitivity induced by 5,7 dihydroxytryptamine lesions
117. Autoradiography of serotonin receptors
118. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazadone, paroxetine, sertraline and venlaflaxine
119. 5-HT(1B) receptor knock-out behavioural consequences
120. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
121. Crystalline serotonin
122. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain
123. Intravenous cocaine self-administration in mice lacking 5-HT(1B) receptors
124. Increased vulnerability to cocaine in mice lacking the serotonin(1B) receptor
125. 7) activating cAMP formation
126. Enhanced aggressive behaviour in mice lacking 5-HT(1B) receptors
127. Serotonin receptors subtypes, functional responses and therapeutic relevance
128. The catecholamine hypothesis of affective disorders: A review of supporting evidence
129. The pharmacological properties of the presynaptic autoreceptor in the pig brain cortex conform to the 5-HT(1D) rectangular subtype
130. Neuronal circuits involved in the anxiolytic effects of 5-HT(1A) receptor agonists 8-OH-DPAT, ipsaspirone and buspirone in the rat
131. 5 receptors positively coupled to the adenyl cyclase in striatal neurons in culture
132. 5-HT and alcohol abuse
133. Molecular cloning and expression of a 5-hydroxytryptamine-7 serotonin receptor subtype
134. Antisense inhibition of 5-hydroxytryptamine(2A) receptor induces an antidepressant-like effect in mice
135. Prophylactic and therapeutic properties of 1-methylsergic acid butanolamide in migraine: Preliminary report
136. Biochemical investigation in headache: Increase in hydroxyindoleacetic acid excretion during migraine attack
137. 7 serotonin receptors: Molecular biology and pharmacology
138. 6 receptors
139. 2 receptor antagonism and slow-wave sleep in major depression
140. 2 receptors antagonists - Potential in the treatment of psychiatric disorders
141. Effects of fenfluramine, m-chlorophenylpiperazine and other serotonin related agonists and antagonists on penile erections in non-human primates
142. 2 receptor binding and on the receptor-mediated behavioural responses of rats
143. Serotonin agents in anxiety
144. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug
145. Eating disorders and epilepsy in mice lacking 5-HT(2C) serotonin receptor
146. Perturbed dentate gyrus function in 5-HT(2C) receptor mutant mice
147. Action of ritanserin and DOI in the elevated X-maze. Psychopharmacology
148. 5-HT(1A) receptor related anxiolytics
149. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: Role of 5-HT(1C) receptor
150. Serotonin content of some mammalian tissues and urine and a method for its detection
151. 5-HT(2B) receptor-mediated calcium release from ryanodine sensitive intracellular stores in human pulmonary artery endothelial cells
152. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug
153. Reduced satieting effect of d-fenfluramine in serotonin (5-HT(2C)) receptor mutant mice
154. Modulation of the serotonin S-2 receptor in brain after chronic lithium treatment
155. Implications of normal brain development for the pathogenesis of schizophrenia
156. Human serotonin(1D) receptor is encoded by a subfamily of 2 distinct genes: 5-HT(1Dα) and 5-HT(1Dβ)
157. A biochemical and pharmacological suggestion about certain mental disorders
158. Pharmacotherapy of OCD
159. 2 receptor changes in major depression
160. 7 receptor gene expression in the rat hippocampus
161. The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation
162. Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment
163. Characterization of a novel serotonin receptor subtype 5-HT(1S) in rat CNS: Interaction with a GTP-binding protein
164. Human gene S31 encodes the pharmacologically defined serotonin(1E) receptor
165. 5-Hydroxytryptamine receptors
166. Serotonergic responsivity in obsessive compulsive disorder: Comparison of patients and healthy controls